Skip to main
ADUS
ADUS logo

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 63%
Hold 0%
Sell 13%
Strong Sell 0%

Bulls say

Addus HomeCare Corp is benefiting from favorable revenue growth in its Personal Care segment, which has exhibited a remarkable +12.3% year-over-year growth in 2023, followed by +7.7% in 2024 and +7.4% year-to-date growth in 2025. The recently finalized +2.6% Medicare Hospice rate increase for FY2026 is expected to further enhance revenue potential for the Hospice segment, alongside anticipated local-level operational improvements driven by leadership changes. Additionally, M&A activity is projected to provide near-term upside, particularly as the Hospice segment stabilizes with consistent growth rates of +5% to +7%.

Bears say

Addus HomeCare has experienced same-store declines due to ongoing Medicaid redeterminations, leading to administrative bottlenecks that hinder patient onboarding and result in higher discharge rates compared to admissions. Approximately 97% of the company's segment revenues as of 2025 year-to-date are affected by uncertainties in the Medicaid funding environment, exacerbated by legislative changes such as the One Big Beautiful Bill Act (OBBBA). Despite strong operational execution and a favorable long-term demand outlook, the equity valuation remains disconnected from the overall earnings trajectory, indicating potential financial instability.

Addus HomeCare (ADUS) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 63% recommend Buy, 0% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 8 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.